LEASE AGREEMENTLease Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyTHIS LEASE AGREEMENT is made this twelfth day of May, 2000, between ARE-TECHNOLOGY CENTER SSF, LLC, a Delaware limited liability company (“Landlord”), and SUNESIS PHARMACEUTICALS, INC., a Delaware corporation (“Tenant”).
SUNESIS PHARMACEUTICALS, INC. INDEMNIFICATION AGREEMENTIndemnification Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc • Delaware
Contract Type FiledDecember 23rd, 2004 Company JurisdictionThis Indemnification Agreement (the “Agreement”) is made as of , 200 by and between Sunesis Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and (the “Indemnitee”).
WARRANT TO PURCHASE 3,000 SHARES OF SERIES C-1 PREFERRED STOCKSunesis Pharmaceuticals Inc • December 23rd, 2004 • Connecticut
Company FiledDecember 23rd, 2004 JurisdictionTHIS CERTIFIES THAT, for value received, General Electric Capital Corporation (“Holder”) is entitled to subscribe for and purchase Three Thousand (3,000) shares of the fully paid and nonassessable Series C-1 Preferred Stock (the “Shares” or the “Preferred Stock”) of Sunesis Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), at the Warrant Price (as hereinafter defined), subject to the provisions and upon the terms and conditions hereinafter set forth. As used herein, the term “Series C-1 Preferred Stock” shall mean the Company’s presently authorized Series C-1 Preferred Stock and any stock into which such Series C-1 Preferred Stock may hereafter be converted or exchanged.
MASTER SECURITY AGREEMENT dated as of June 15, 2000 (“Agreement”)Master Security Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyTHIS AGREEMENT is between General Electric Capital Corporation (together with its successors and assigns, if any, “Secured Party”), and Sunesis Pharmaceuticals Incorporated (“Debtor”). Secured Party has an office at 5150 EI Camino Real, Suite B-21, Los Altos, CA 94022. Debtor is a corporation organized and existing under the laws of the state of Delaware. Debtor’s mailing address and chief place of business is 3696 Haven Avenue, Suite C, Redwood City, CA 94063.
First Amendment to Employment Agreement dated December 1, 2003First Amendment • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 Company
Modified Employment AgreementModified Employment Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyIn connection with the desire of Sunesis Pharmaceuticals Incorporated (the “Company”) to realign certain reporting and staffing relationships within the Company, and in recognition that changes in your reporting relationships might trigger certain rights under your employment agreement entered into with the Company on or about March 23, 2000, we have discussed appropriate modifications to your employment agreement and have agreed on the following modified agreement:
EIGHTH AMENDED AND RESTATED INVESTOR RIGHTS AGREEMENTInvestor Rights Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc • California
Contract Type FiledDecember 23rd, 2004 Company JurisdictionThis Eighth Amended and Restated Investor Rights Agreement (this “Agreement”) is entered into as of August 30, 2004 by and among Sunesis Pharmaceuticals Incorporated, a Delaware corporation (the “Company”), Alexandria Real Estate Equities, L.P., a Delaware limited partnership (“Alexandria”), the holder or holders of that certain warrant, dated May 10, 1998, to purchase 175,000 shares (the “Warrant Stock”) of the Company’s Common Stock, and the holders of the Company’s Series A Preferred Stock (the “Series A Preferred Stock”), Series B Preferred Stock (the “Series B Preferred Stock”), Series C Preferred Stock (the “Series C Preferred Stock”) and Series C-1 Preferred Stock (“Series C-1 Preferred Stock”) listed on Exhibit A attached hereto (collectively with Alexandria, the “Prior Investors”) and the purchaser of the Company’s Series C-2 Preferred Stock, Biogen Idec MA, a Massachusetts corporation (the “Additional Investor”). The Prior Investors and the Additional Investor are collectivel
EMPLOYMENT AGREEMENTEmployment Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyOn behalf of Sunesis Pharmaceuticals, Incorporated (the “Company”), I am pleased to offer you the position of Chief Financial Officer. Speaking for myself, as well as the other members of the Company’s Executive Committee, we look forward to working with you and to your future success as Sunesis’ CFO.
EMPLOYMENT AGREEMENTEmployment Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyOn behalf of Sunesis Pharmaceuticals, Incorporated (the “Company”), I am pleased to offer you the position of Chief Executive Officer (CEO). Speaking for myself, as well as the other members of the Company’s Board of Directors, we look forward to working with you and to your future success as Sunesis’ CEO.
EMPLOYMENT AGREEMENTEmployment Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc • California
Contract Type FiledDecember 23rd, 2004 Company JurisdictionThis Agreement is entered into as of April 9, 1998 (the “Effective Date”), by and between MOSAIC PHARMACEUTICALS, INC., a Delaware corporation (the “Company”), and JAMES A. WELLS (the “Employee”).
FIRST AMENDMENT TO LEASE AGREEMENTLease Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyThis First Amendment to Lease Agreement (the “First Amendment”) is made as of December 20, 2000, by and between ARE-Technology Center SSF, LLC, a Delaware limited liability company, having an address at 135 North Los Robles Avenue, Suite 250, Pasadena, California 91101 (“Landlord”), and Sunesis Pharmaceuticals, Inc., a Delaware corporation, having an address at 3696 Haven Avenue, Suite C, Redwood City, California 94063 (“Tenant”).
EMPLOYMENT AGREEMENTEmployment Agreement • December 23rd, 2004 • Sunesis Pharmaceuticals Inc
Contract Type FiledDecember 23rd, 2004 CompanyOn behalf of Sunesis Pharmaceuticals, Incorporated (the “Company”), I am pleased to offer you the new position of Executive Chairman of the Board of Directors. Speaking for myself, as well as the other members of the Company’s Board of Directors, we look forward to working with you and to your future success as Sunesis’ Executive Chairman.